Skip to main content
Erschienen in: European Archives of Paediatric Dentistry 2/2023

07.02.2023 | Original Scientific Article

Decreased salivary beta-defensin 2 in children with asthma after treatment with corticosteroid inhaler

verfasst von: M.-S. Moosavi, P.-S. Hosseinizade, G. Panahi, M. Shariat

Erschienen in: European Archives of Paediatric Dentistry | Ausgabe 2/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Asthma is the most common chronic disorder in childhood. Inhaled corticosteroid therapy is currently the most effective treatment for Asthma. The oral cavity complications related to this treatment may be in terms of the changes in the innate immune system of mouth. Salivary defensin has many immunomodulatory properties. The expression of beta-defensin 2 was measured before and after inhaled corticosteroid treatment in children with asthma to determine the potential impact of corticosteroids on defensin expression.

Methods

The present study was a cohort study conducted on the patients referred to Children’s Medical Center for whom a diagnosis of Asthma was confirmed, and inhaled corticosteroid therapy was prescribed. Saliva was sampled once at the stage of diagnosis and before receiving any treatment. Another salivary sample was collected 4 weeks after receiving corticosteroids. ELISA was performed to assess beta-defensin 2.

Results

The beta-defensin 2 salivary level after inhaled corticosteroid therapy was significantly lower than before treatment. There is no significant difference in the salivary flow rate before and after treatment.

Conclusions

Considering the limitations of the present study, the following conclusions can be made salivary beta-defensin 2 is decreased in children with asthma after treatment with a corticosteroid inhaler. Regular dental and oral soft tissue examinations in Asthmatic children under corticosteroid therapy could be suggested.
Literatur
Zurück zum Zitat Cogen AL, Walker SL, Roberts CH, Hagge DA, Neupane KD, Khadge S, Lockwood DN. Human beta-defensin 3 is up-regulated in cutaneous leprosy type 1 reactions. PLoS Negl Trop Dis. 2012;6: e1869.CrossRefPubMedPubMedCentral Cogen AL, Walker SL, Roberts CH, Hagge DA, Neupane KD, Khadge S, Lockwood DN. Human beta-defensin 3 is up-regulated in cutaneous leprosy type 1 reactions. PLoS Negl Trop Dis. 2012;6: e1869.CrossRefPubMedPubMedCentral
Zurück zum Zitat Ektah K, Arun RJ, Elza T. Oral findings in asthmatic children. Amrita J Med. 2014;10:1–4. Ektah K, Arun RJ, Elza T. Oral findings in asthmatic children. Amrita J Med. 2014;10:1–4.
Zurück zum Zitat Hernandez-Pacheco N, Gorenjak M, Li J, Repnik K, Vijverberg SJ, Berce V, Jorgensen A, Karimi L, Schieck M, Samedy-Bates L-A. Identification of ROBO2 as a potential locus associated with inhaled corticosteroid response in childhood asthma. J Person Med. 2021;11:733.CrossRef Hernandez-Pacheco N, Gorenjak M, Li J, Repnik K, Vijverberg SJ, Berce V, Jorgensen A, Karimi L, Schieck M, Samedy-Bates L-A. Identification of ROBO2 as a potential locus associated with inhaled corticosteroid response in childhood asthma. J Person Med. 2021;11:733.CrossRef
Zurück zum Zitat Kulhava L, Eckhardt A, Pataridis S, Foltan R, Miksik I. Proteomic analysis of whole saliva in relation to dental caries resistance. Folia Biol (Praha). 2020;66:72–80.PubMed Kulhava L, Eckhardt A, Pataridis S, Foltan R, Miksik I. Proteomic analysis of whole saliva in relation to dental caries resistance. Folia Biol (Praha). 2020;66:72–80.PubMed
Zurück zum Zitat Macredmond RE, Greene CM, Dorscheid DR, McElvaney NG, O’Neill SJ. Epithelial expression of TLR4 is modulated in COPD and by steroids, salmeterol and cigarette smoke. Respir Res. 2007;8:1–12.CrossRef Macredmond RE, Greene CM, Dorscheid DR, McElvaney NG, O’Neill SJ. Epithelial expression of TLR4 is modulated in COPD and by steroids, salmeterol and cigarette smoke. Respir Res. 2007;8:1–12.CrossRef
Zurück zum Zitat Navazesh M, Kumar SK. Measuring salivary flow: challenges and opportunities. J Am Dent Assoc. 2008;139:35S-40S.CrossRefPubMed Navazesh M, Kumar SK. Measuring salivary flow: challenges and opportunities. J Am Dent Assoc. 2008;139:35S-40S.CrossRefPubMed
Zurück zum Zitat Peona V, Amici MD, Quaglini S, Bellaviti G, Castellazzi AM, Marseglia G, Ciprandi G. Serum eosinophilic cationic protein: is there a role in respiratory disorders? J Asthma. 2010;47:131–4.CrossRefPubMed Peona V, Amici MD, Quaglini S, Bellaviti G, Castellazzi AM, Marseglia G, Ciprandi G. Serum eosinophilic cationic protein: is there a role in respiratory disorders? J Asthma. 2010;47:131–4.CrossRefPubMed
Zurück zum Zitat Singanayagam A, Glanville N, Cuthbertson L, Bartlett NW, Finney LJ, Turek E, Bakhsoliani E, Calderazzo MA, Trujillo-Torralbo MB, Footitt J, James PL, Fenwick P, Kemp SV, Clarke TB, Wedzicha JA, Edwards MR, Moffatt M, Cookson WO, Mallia P, Johnston SL. Inhaled corticosteroid suppression of cathelicidin drives dysbiosis and bacterial infection in chronic obstructive pulmonary disease. Sci Transl Med. 2019;11:eaav3879. https://doi.org/10.1126/scitranslmed.aav3879.CrossRefPubMedPubMedCentral Singanayagam A, Glanville N, Cuthbertson L, Bartlett NW, Finney LJ, Turek E, Bakhsoliani E, Calderazzo MA, Trujillo-Torralbo MB, Footitt J, James PL, Fenwick P, Kemp SV, Clarke TB, Wedzicha JA, Edwards MR, Moffatt M, Cookson WO, Mallia P, Johnston SL. Inhaled corticosteroid suppression of cathelicidin drives dysbiosis and bacterial infection in chronic obstructive pulmonary disease. Sci Transl Med. 2019;11:eaav3879. https://​doi.​org/​10.​1126/​scitranslmed.​aav3879.CrossRefPubMedPubMedCentral
Zurück zum Zitat van der Velden HM, Pasch MC, van Erp PE, van Lingen RG, Otero ME, de Boer-van Huizen RT, van de Kerkhof PC. Treatment of plaque psoriasis with the two-compound product calcipotriol/betamethasone dipropionate versus both monotherapies: an immunohistochemical study. J Dermatol Treat. 2010;21:13–22.CrossRef van der Velden HM, Pasch MC, van Erp PE, van Lingen RG, Otero ME, de Boer-van Huizen RT, van de Kerkhof PC. Treatment of plaque psoriasis with the two-compound product calcipotriol/betamethasone dipropionate versus both monotherapies: an immunohistochemical study. J Dermatol Treat. 2010;21:13–22.CrossRef
Zurück zum Zitat Wozniak M, Paluszkiewicz C, Kwiatek W. Saliva as a non-invasive material for early diagnosis. Acta Biochim Pol. 2019;66:383–8.PubMed Wozniak M, Paluszkiewicz C, Kwiatek W. Saliva as a non-invasive material for early diagnosis. Acta Biochim Pol. 2019;66:383–8.PubMed
Metadaten
Titel
Decreased salivary beta-defensin 2 in children with asthma after treatment with corticosteroid inhaler
verfasst von
M.-S. Moosavi
P.-S. Hosseinizade
G. Panahi
M. Shariat
Publikationsdatum
07.02.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
European Archives of Paediatric Dentistry / Ausgabe 2/2023
Print ISSN: 1818-6300
Elektronische ISSN: 1996-9805
DOI
https://doi.org/10.1007/s40368-022-00776-w

Weitere Artikel der Ausgabe 2/2023

European Archives of Paediatric Dentistry 2/2023 Zur Ausgabe

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Update Zahnmedizin

Bestellen Sie unseren kostenlosen Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.